Literature DB >> 12012125

Gender-related differences in prolactin secretion in pituitary prolactinomas.

H Nishioka1, J Haraoka, K Akada, S Azuma.   

Abstract

In pituitary prolactinomas, serum prolactin (PRL) levels usually parallel the tumor size. We conducted a retrospective study to determine differences in PRL production between men and women with prolactinomas. A total of 51 patients, 16 men and 35 women, was studied. We investigated clinical, endocrinological, radiological and histological findings, and estimated the tumor volume (TV) by high-resolution magnetic resonance imaging (MRI). Correlation between PRL level and TV was low in men (R=0.458), in contrast to women (R=0.953), c. Men with prolactinomas showed predominance of large tumors (P=0.0009) with high PRL levels (P=0.0009) and had greater tendencies for cyst formation (P=0.0047). Large prolactinomas tended to be accompanied by cyst(s) (P=0.0051) and hemorrhage ( P=0.0015), both of which were associated with reduced PRL secretion (P=0.0004 and P<0.0001, respectively). When the volume of the cysts and hemorrhage was subtracted from the total TV, correlation between PRL level and TV became greater (R=0.905) with no gender difference. Histological examination demonstrated a sparsely granulated type of lactotroph adenoma with occasional fibrosis, particularly in tumors with hemorrhage and cysts. Although a significant discrepancy between PRL level and TV may exist in prolactinomas when intratumoral hemorrhage and/or cysts are present, there is no essential difference in PRL secretion between the sexes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12012125     DOI: 10.1007/s00234-002-0774-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Authors:  Maria Menucci; Alfredo Quiñones-Hinojosa; Peter Burger; Roberto Salvatori
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

Review 2.  Management of cystic prolactinomas: a review.

Authors:  Afif Nakhleh; Naim Shehadeh; Irit Hochberg; Moshe Zloczower; Sagit Zolotov; Riad Taher; Deeb Daoud Naccache
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

3.  Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.

Authors:  Julie Kreutz; Laurent Vroonen; Francoise Cattin; Patrick Petrossians; Albert Thiry; Liliya Rostomyan; Luaba Tshibanda; Albert Beckers; Jean-François Bonneville
Journal:  Neuroradiology       Date:  2015-04-07       Impact factor: 2.804

4.  T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.

Authors:  M C Burlacu; D Maiter; T Duprez; E Delgrange
Journal:  Endocrine       Date:  2018-09-28       Impact factor: 3.633

5.  Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression.

Authors:  Ilan Shimon; Carlos Benbassat; Gloria Tzvetov; Simona Grozinsky-Glasberg
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

6.  Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.

Authors:  Niraj Mohan; Yi Yan Chia; Giap Hean Goh; Eric Ting; Kejia Teo; Tseng Tsai Yeo
Journal:  BMJ Case Rep       Date:  2017-11-03

7.  Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study.

Authors:  Winnie Liu; Roula Shraiky Zahr; Shirley McCartney; Justin S Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

8.  Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.

Authors:  Bianca M Leca; Maria Mytilinaiou; Marina Tsoli; Andreea Epure; Simon J B Aylwin; Gregory Kaltsas; Harpal S Randeva; Georgios K Dimitriadis
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

9.  Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.

Authors:  Ryosuke Mori; Naoko Inoshita; Junko Takahashi-Fujigasaki; Tatsuhiro Joki; Hiroshi Nishioka; Toshiaki Abe; Takeshi Fujii; Shozo Yamada
Journal:  ISRN Endocrinol       Date:  2013-01-21

10.  Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery.

Authors:  Grzegorz Zielinski; Marcin Ozdarski; Maria Maksymowicz; Katarzyna Szamotulska; Przemysław Witek
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.